Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Chinese Journal of Pathology ; (12): 785-790, 2023.
Artigo em Chinês | WPRIM | ID: wpr-1012308

RESUMO

Objective: To investigate the clinicpathological characteristics of ALK-positive anaplastic large cell lymphoma (ALCL) of the gastrointestinal tract, and to discuss its diagnosis and differential diagnosis. Methods: Five cases of gastrointestinal ALK-positive ALCL diagnosed and treated in Xijing Hospital of the Fourth Military Medical University, between 2011 and 2019 were collected. There were three male and two female patients, aged 5-42 years (mean 25 years). These patients clinically presented with fever and night sweats, weight loss, abdominal pain, abdominal mass, ulcers, bleeding, or intestinal obstruction, and underwent surgical resection of the tumors or endoscopic biopsy. The clinical manifestations, auxiliary examinations, histopathological characteristics, immunophenotypes and genetic alterations were analyzed. Results: In this cohort, one case was common type, two cases were monomorphic variant of common type, and two cases were small cell variant. The tumor cells in all cases expressed ALK, CD30, and one or more T lymphocyte markers, while all the markers of B lymphocyte and plasmacyte were negative. Clonality analysis showed that two cases had clonal T cell receptor (TCR) and immunoglobulin (Ig) gene rearrangement, one case had no clonal TCR but Ig gene rearrangement, and one case had no clonal TCR and Ig gene rearrangements. During the 4 to 67 months' follow-up, two patients died of the disease, two were alive with free of disease and one had a relapse. Conclusions: ALK-positive ALCL of the gastrointestinal tract is extremely rare, and has poor prognosis. Lymphoma originating from this site with CD30 and ALK-positive phenotypes may be considered to be ALCL; however differentiation from other tumors that had anaplastic features, expressed CD30 and or ALK, in particular, ALK positive large B-cell lymphoma is necessary.


Assuntos
Masculino , Feminino , Humanos , Linfoma Anaplásico de Células Grandes/patologia , Receptores Proteína Tirosina Quinases/genética , Quinase do Linfoma Anaplásico , Trato Gastrointestinal/patologia , Linfoma Difuso de Grandes Células B/genética
2.
Autops. Case Rep ; 11: e2020231, 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1153176

RESUMO

Cardiac lymphoma is a rare entity. In this setting, the secondary involvement of the heart is far more frequent than the primary cardiac lymphoma. Herein, we present an autopsy case of a disseminated anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma with a dominant mediastinal involvement. Extensive cardiac infiltration with the near replacement of the myocardial wall by the neoplastic cells was observed. A total of nine isolated case reports of anaplastic large cell lymphoma with cardiac involvement were found in the English-language literature, and a widespread cardiac and thymic infiltration by the systemic ALK-positive anaplastic large cell lymphoma has not been documented. An incidental regenerative nodule was also identified in the liver. The patient died of pulmonary thromboembolism and cardiac arrest.


Assuntos
Humanos , Feminino , Adulto , Linfoma Anaplásico de Células Grandes/patologia , Neoplasias Cardíacas , Autopsia , Tromboembolia , Timo/patologia , Evolução Fatal , Quinase do Linfoma Anaplásico , Parada Cardíaca
3.
Arq. bras. oftalmol ; 82(6): 514-516, Nov.-Dec. 2019. graf
Artigo em Inglês | LILACS | ID: biblio-1038694

RESUMO

ABSTRACT Ocular adnexal involvement in CD30+ lymphoproliferative disorders is rare. We report the case of a 73-year-old woman with a relapsing primary cutaneous anaplastic large cell lymphoma on her eyelid. A systemic extension study excluded extracutaneous involvement. Systemic chemotherapy resulted in an optimal response, with complete regression of the cutaneous lesions. There has been no recurrence during the 2 years of follow-up.


RESUMO O acometimento ocular adicional nos distúrbios linfoproliferativos CD30+ é raro. Relatamos o caso de uma mulher de 73 anos com linfoma de grandes células anaplásicas primárias recidivantes em sua pálpebra. A avaliação sistêmica excluiu envolvimento extracutâneo. A quimioterapia sistémica resultou em uma resposta ótima, com regressão completa das lesões cutáneas. Não houve recidiva durante 2 anos de acompanhamento.


Assuntos
Humanos , Feminino , Idoso , Linfoma Anaplásico de Células Grandes/patologia , Neoplasias Palpebrais/patologia , Biópsia , Resultado do Tratamento , Linfoma Anaplásico de Células Grandes/tratamento farmacológico , Neoplasias Palpebrais/tratamento farmacológico
4.
Gac. méd. Méx ; 155(2): 130-135, mar.-abr. 2019. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1286473

RESUMO

Resumen Introducción: El linfoma anaplásico de células T grandes CD30+ es un linfoma primario cutáneo en el cual no hay evidencia de enfermedad sistémica; para su diagnóstico es necesario el estudio histopatológico. Objetivo: Presentar los casos diagnosticados en el Departamento de Dermatología del Hospital General "Dr. Manuel Gea González" con linfomas anaplásicos de células T grandes primarios cutáneos CD30+ durante un periodo de 24 años. Método: Estudio retrospectivo en el que realizó estadística descriptiva. Se recopiló información de sexo, edad, características clínicas, resultados de pruebas complementarias, tratamientos previos y actuales, reportes de los estudios histopatológicos y de inmunohistoquímica. Resultados: Entre 29 309 expedientes, se encontraron nueve casos (0.000034 %) con diagnóstico de linfoma anaplásico de células T CD30+. Se hizo la confirmación del diagnóstico histopatológico e inmunohistoquímico por dos dermatopatólogos certificados. La edad promedio fue de 61.2 años, hubo predominio del sexo femenino y de lesión papular o nodular y topografía variada como presentación clínica inicial. Conclusiones: El pronóstico del linfoma anaplásico de células T grandes CD30+ en la población estudiada fue dependiente del estadio clínico. El tratamiento en etapas tempranas tiene resultados favorables.


Abstract Introduction: CD30+ anaplastic large T cell lymphoma is a cutaneous primary lymphoma in which there is no evidence of systemic disease; histopathological study is required for its diagnosis. Objective: To present the cases diagnosed with primary cutaneous CD30+ anaplastic large T-cell lymphoma over a 24-year period in Hospital General "Dr. Manuel Gea González" Department of Dermatology. Method: Retrospective study. Descriptive statistics was carried out. Information was collected on gender, age, clinical characteristics, complementary test results, previous and current treatments, histopathological studies reports and immunohistochemistry test results. Results: Of 29 309 records, nine patients (0.000034%) with a diagnosis of CD30+ anaplastic T cell lymphoma were found. Histopathological and immunohistochemical diagnosis was confirmed by two certified dermatopathologists. Average age was 61.2 years, and there was a predominance of the female gender, with initial clinical presentation as a papular or nodular lesion and varied topography. Conclusions: The prognosis of CD30+ anaplastic large T cell lymphoma in the studied population was dependent on clinical stage. The treatment at early stages has favorable results.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Neoplasias Cutâneas/patologia , Linfoma Anaplásico de Células Grandes/patologia , Antígeno Ki-1/metabolismo , Prognóstico , Neoplasias Cutâneas/diagnóstico , Estudos Retrospectivos , Linfoma Anaplásico de Células Grandes/diagnóstico , Estadiamento de Neoplasias
5.
Indian J Pathol Microbiol ; 2011 Jul-Sept 54(3): 599-602
Artigo em Inglês | IMSEAR | ID: sea-142055

RESUMO

Anaplastic large cell lymphoma (ALCL) is a distinct type of CD30+ T/null-cell non-Hodgkin's lymphoma that frequently involves nodal and extranodal sites. The presence of leukemic phase in ALCL is extremely rare and occurs exclusively with ALK1-positive ALCL. We describe two patients with ALK1-positive ALCL who developed a leukemic phase with rapid progression of the disease. Immunophenotypic pattern assessed on peripheral blood by flow cytometry revealed CD45, CD30, and CD25 positivity in both cases but NPM-ALK1 was expressed in only one case. Both patients developed leukemic phase as a terminal event of the disease and we share the immunophenotypic features of both cases.


Assuntos
Adolescente , Antígeno Ki-1/análise , Antígenos Comuns de Leucócito/análise , Criança , Progressão da Doença , Feminino , Citometria de Fluxo , Humanos , Subunidade alfa de Receptor de Interleucina-2/análise , Leucemia Linfoide/patologia , Leucócitos Mononucleares/química , Linfoma Anaplásico de Células Grandes/complicações , Linfoma Anaplásico de Células Grandes/diagnóstico , Linfoma Anaplásico de Células Grandes/patologia , Masculino , Receptores Proteína Tirosina Quinases/metabolismo
6.
Arch. argent. dermatol ; 60(3): 95-99, 2010. ilus
Artigo em Espanhol | LILACS | ID: lil-648068

RESUMO

Los linfomas CD30+ de la piel representan un grupo heterogéneo de neoplasias con morfología, inmunofenotipo y clínica variables: en un extremo del espectro se encuentra la papulosis linfomatoide, de curso generalmente indolente, y en el otro extremo, el agresivo linfoma anaplásico de células grandes CD30+ (ALCL) sistémico. Presentamos una paciente de sexo femenino de 48 años de edad, con diagnóstico de ALCL con mala evolución. Analizaremos a continuación aspectos fundamentales del diagnóstico y tratamiento de esta patología.


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Linfoma Anaplásico de Células Grandes/imunologia , Linfoma Anaplásico de Células Grandes/patologia , Dermatopatias/imunologia , Dermatopatias/patologia
7.
An. bras. dermatol ; 84(3): 270-274, jul. 2009. ilus
Artigo em Inglês, Espanhol | LILACS | ID: lil-521752

RESUMO

Se presenta un caso de lesión tumoral de rápido crecimiento en la parte posterior del brazo derecho de una paciente de sexo femenino de 37 años de edad. Son discutidas las características dermatopatológicas e inmuno histoquímicas que determinan el diagnóstico definitivo.


It is a case of fast growth tumor lesion on the posterior region of the right arm of a 37-year-old female patient. Dermatopathological and immunohistochemical characteristics are discussed to support the definite diagnosis.


Assuntos
Adulto , Feminino , Humanos , Linfoma Anaplásico de Células Grandes/patologia , Neoplasias Cutâneas/patologia , Pele/patologia , Braço , Biópsia , Metástase Linfática , Linfoma Anaplásico de Células Grandes/cirurgia , Neoplasias Cutâneas/cirurgia
10.
Arch. med. interna (Montevideo) ; 16(3): 101-5, set. 1994. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-189864

RESUMO

Presentamos los tres primeros casos nacionales de linfoma de grandes celulas anaplasticas (Ki 1+), cubriendo las tres variedades morfologicas de este tipo de linfoma descritas en la literatura internacional. Su correcto diagnostico estuvo basado en la deteccion IHQ de BER-H2, obviando las dificultades del diagnostico diferencial basado en hechos exclusivamente morfologicos. A pesar de la frecuencia relativamente baja de este tipo de linfoma, su tipificacion exacta resulta de suma importancia ya que existen pacientes con una evolucion mucho mas favorable que lo que habitualmente tienen los linfomas de alto grado


Assuntos
Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Humanos , Linfoma Anaplásico de Células Grandes/diagnóstico , Linfoma Anaplásico de Células Grandes/imunologia , Linfoma Anaplásico de Células Grandes/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA